i recently bought back a stack of ksx having checked out the last six months of announcements. the ex-resmed execs were the catalyst for me deciding to come on board. unlike the pbi fiasco it shows that management are keen to progress these technologies through to sales.
great thing with the ksx tech is that its meeting an unmet need, there are recurring revenue models (through sales of home use units, disposable pads, servicing, data collection etc) .... from all reports the uptake of this machines will be strong from the outset; this really puts the oppies in the frame with 15 months until expiry. i can see a situation where the ords are at the strike price of .07 within the next six weeks. watch out when they release the mooted revenue modelling for asia pacific region alone. i suspect the numbers will blow the socks of the doubters.
remember resmed had one unique product and is now a billion dollar company. ksx has three unique products. anyone think cashed u resmed is going to sit around and let its ex-execs and an upstart company syphon away a whole new lucrative stream of business ??? takeover bid sooner rather than later if it stays at these prices.
KSX Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
